U.S. oncology group rates blood cancer regimens, including cost 16.10.2015 23:58 Reuters (Reuters) - The most influential source for U.S. oncology treatment guidelines on Friday unveiled ratings aimed at helping doctors and patients assess the costs versus benefits of current therapies for two types of blood cancer.
